Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2010-10-07 14:17:00

NASHVILLE, Tenn., Oct. 7 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of data affirming the safety and efficacy of Caldolor® (ibuprofen) Injection in treating fever in critically ill and non-critically ill adults. Published in the peer-reviewed journal Critical Care, the study showed that IV ibuprofen was significantly more effective at reducing fever in hospitalized patients than placebo. "These findings demonstrate...

2010-10-06 09:23:00

NEW YORK, Oct. 6 /PRNewswire/ -- For Joy Behar - comedienne, television host, author and mother - heart disease is a family affair. Despite having lost both parents to heart disease, Joy's mother Rose was not prepared when a sudden heart attack struck in her fifties. Now, Joy and her daughter, Eve, are challenging women who have or are at risk for heart disease to be prepared and better their odds of surviving should a heart attack strike without warning. And they caution women, "don't...

2010-10-04 13:01:00

MADISON, N.J., Oct. 4 /PRNewswire-FirstCall/ -- Pfizer Consumer Healthcare, maker of Advil® pain-relief products, announced today the launch of a consumer campaign encouraging Americans to clean out their medicine cabinets and properly dispose of unwanted, expired and recalled products. A recent poll shows that nearly half of Americans do not always look at the expiration date on over-the-counter medications before taking them.(1) (Photo:...

2010-10-04 08:00:00

SEOUL, South Korea, Oct. 4 /PRNewswire/ -- CrystalGenomics, Inc. (Seoul, Korea) and CG Pharmaceuticals, Inc. (Emeryville, California), a drug discovery and development biopharmaceutical company, has announced that Dr. William Schmidt, its Vice President of Clinical Development, has been invited to present a talk on "Development of CG100649, Tissue-selective Dual Inhibitor of COX-2 and Carbonic Anhydrase for Treatment of Osteoarthritis" at Arrowhead's upcoming 4th Annual Pain Therapeutics...

2010-09-20 23:20:51

A new study shows that aspirin, given intravenously (IV), may be a safe and effective option for people hospitalized for severe headache or migraine, undergoing medication withdrawal. The research will be published in the September 21, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology. "Intravenous aspirin is not readily available in the United States and only on a 'named patient' basis in the United Kingdom, while it is more generally used...

2010-09-16 13:03:01

Effect of aspirin and NSAIDS on risk and survival from colorectal cancer Even the lowest possible dose of aspirin (75 mg) can ward off bowel cancer, if taken regularly, finds research published online in the journal Gut. This protective effect is apparent after just one year and in the general population, not just those considered to be at risk of developing the disease, which is the second most common cause of cancer death in the world, killing almost half a million people every year....

2010-09-13 15:24:00

PARSIPPANY, N.J. and INDIANAPOLIS, Sept. 13 /PRNewswire-FirstCall/ -- A study evaluating the level of platelet aggregation achieved after switching from Plavix® (clopidogrel) 75 mg once-daily maintenance dosing plus aspirin to Effient® (prasugrel) 10 mg once-daily maintenance dosing (MD) in patients with acute coronary syndrome (ACS) was published today in the Journal of the American College of Cardiology. In this Phase II study, ACS patients who were...

2010-09-08 07:00:00

BEDMINSTER, N.J. and BALERNA, Switzerland, Sept. 8 /PRNewswire/ -- Nautilus Neurosciences, Inc. ("Nautilus"), a neurology-focused specialty pharmaceutical company headquartered in New Jersey, and APR Applied Pharma Research s.a. ("APR"), a leading drug developer and delivery technology provider based in Switzerland, announced today that CAMBIA(TM) (diclofenac potassium for oral solution) is now protected by an additional Orange Book listed patent through June 16, 2026. CAMBIA(TM) is...

2010-09-02 07:00:00

MONTREAL, Sept. 2 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced today the final data set from its Phase 3 study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada. TDLP-110, the Company's lead pain product candidate, utilizes its transdermal delivery...

710cd4b16f34a75d6e5c40ddc284068f1
2010-08-20 07:59:25

Researchers, in a new study, found that common painkillers that have been linked to risks of heart attack may also increase the risk of stroke.Nearly 38,000 Taiwanese adults who suffered a stroke over one year, researchers found the use of a non-steroidal anti-inflammatory drug (NSAID) in the month prior to the stroke may have elevated that risk.Results of the study were reported in the medical journal Stroke. Researchers said the increases linked to individual NSAID use were generally...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related